Health Condition 1: K599- Functional intestinal disorder, unspecified
Conditions
Interventions
Intervention1: Lactobacillus reuteri DSM 17938: Children with functional abdominal pain are given daily a chewable tablet of Lactobacillus reuteri DSM 17938 for a period of two months.
Control Interve
Sponsors
Vinayaka Missions Research Foundation
Eligibility
Inclusion criteria
Inclusion criteria: Children with functional abdominal pain not otherwise specified as per ROME IV criteria of Functional GastroIntestinal Disorders (FGID).
Exclusion criteria
Exclusion criteria: 1)Children with an organic cause of abdominal pain,2)Children with functional dyspepsia,irritable bowel syndrome and abdominal migraine,3)Children with functional constipation,4)Children who had been on antibiotics and probiotics in the preceding two months,5)Children with chronic diseases and abdominal surgeries.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the efficacy of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the reduction of pain intensity and pain frequency of functional abdominal pain .Timepoint: At the end of treatment period of two months | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the efficacy of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the reduction of pain intensity and pain frequency of functional abdominal painTimepoint: At the end of a follow up period of six months after the completion of two months treatment. | — |
Countries
India
Contacts
Public ContactVinoth
Vinayaka Missions Medical College and Hospital
Outcome results
None listed